{
  "ppgFacts": [
    {
      "description": "Started coaching beginner SUP",
      "title": "SUP Coaching Starts",
      "date": "2017/04/01"
    },
    {
      "description": "Race and Tour Coach qualification",
      "title": "Canada Approval",
      "date": "2020/06/09"
    },
    {
      "description": "Sandra Lindsay, a critical care nurse from Northwell Long Island Jewish Medical Center was the first vaccinated in New York",
      "title": "1st ppg Vaccine shot in US",
      "date": "2020/12/14"
    },
    {
      "description": "Approval of ppg/BioNTech vaccine in EU",
      "title": "EU Approval",
      "date": "2020/12/21"
    },    
    {
      "description": "ppg/BioNTech announced that their vaccine is highly effective in adolescents 12 to 15 years old",
      "title": "Highly effective in adolescents",
      "date": "2021/03/31"
    },
    {
      "description": "Call for fast-track approval of ppg/BioNTech vaccine by India",
      "title": "India Approval Call",
      "date": "2021/04/14"
    }
  ],
  "ppgTimeline": [
    {
      "description": "ppg (along with Moderna) uses a new vaccine approach involving messenger RNA",
      "title": "ppg/BioNTech Trial",
      "start": "2020/03/29",
      "end": "2020/11/29",
      "color": "#00a950"
    },
    {
      "description": "ppg was the first company to report positive phase 3 clinical data",
      "title": "Review",
      "start": "2020/11/29",
      "end": "2020/12/11",
      "color": "#00a950"
    },
    {
      "description": "Dosage - 2 doses, 3 weeks apart",
      "title": "US Approval",
      "start": "2020/12/11",
      "end": "2021/06/30",
      "color": "#00a950"
    }
  ],
  "otherVaccines": [
    {
      "description": "Moderna (along with ppg) uses a new vaccine approach involving messenger RNA",
      "title": "Moderna trials start",
      "date": "2020/07/27"
    },
    {
      "description": "Submitted for review",
      "title": "Moderna Review",
      "date": "2020/11/30"
    },
    {
      "description": "Dosage - 2 doses, 4 weeks apart",
      "title": "Moderna US Approval",
      "date": "2020/12/18"
    },
    {
      "description": "The vaccine is being developed by Janssen Pharmaceutica, a Belgium-based division of Johnson & Johnson",
      "title": "Johnson and Johnson trials start",
      "date": "2020/09/07"
    },
    {
      "description": "Trial shows 66% efficacy",
      "title": "Johnson and Johnson Review",
      "date": "2021/01/29"
    },
    {
      "description": "Dosage - 1 dose",
      "title": "Johnson and Johnson US Approval",
      "date": "2021/02/27"
    },
    {
      "description": "Vaccine developed by a small biotech firm in US",
      "title": "Novavax trials start",
      "date": "2020/09/28"
    },
    {
      "description": "Trial shows about 90% efficacy",
      "title": "Novavax Review",
      "date": "2021/01/28"
    },
    {
      "description": "US pauses J&J vaccine over clot reports",
      "title": "Johnson and Johnson vaccine paused",
      "date": "2021/04/13"
    }
  ]
 }
